ArticleClinical and public health guidelines2025
Advancing health equity: Why guideline development must prioritize fairness and justice.
Article in Clinical and public health guidelines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health equity should be regarded as a fundamental principle and a priority for all guideline development organizations. Yet, this principle has not been consistently prioritized in the creation of mainstream guidelines. In this commentary, we examine a real-world example from leprosy management, where the initial lack of integration of health equity considerations in the guideline recommendations did not consider the potential impact of the recommendations on the health of populations most affected by leprosy. We also highlight subsequent changes in the guideline development process that reflect stronger consideration of health equity, addressing some of the previous issues propagated with historical practices. We also draw on other examples from several fields to further illustrate the impact of integrating health equity considerations in guidelines. Building on evaluations of guidelines for health equity and real-world experiences, we highlight some of the common challenges in integrating health equity considerations in the guideline development process. We propose potential solutions using existing tools and frameworks and outlining key research priorities to further advance this goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.